Metabolic Improvements and Weight Trajectories After Metabolic-Bariatric Surgery in Women with Polyendocrine Metabolic Ovarian Syndrome - Scorecard - MDSpire
Clinical Scorecard: Metabolic Enhancements and Weight Patterns Following Bariatric Surgery in Women Diagnosed with Polyendocrine Metabolic Ovarian Syndrome
At a Glance
Category
Detail
Condition
Polyendocrine Metabolic Ovarian Syndrome (PMOS)
Key Mechanisms
Bariatric surgery improves BMI, metabolic profiles, ovulation, and hormonal disturbances.
Target Population
Women aged 18-50 with obesity and PMOS.
Care Setting
Bariatric surgery in a clinical hospital setting.
Key Highlights
Obesity affects 50% to 80% of women with PMOS.
MBS significantly improves BMI and metabolic profiles in PMOS patients.
79.03% of PMOS patients experience resolution of irregular menstruation post-surgery.
Fasting insulin concentrations decrease from 34.2 mIU/mL to 9.0 mIU/mL after MBS.
20-30% of patients may experience inadequate weight loss or weight regain postoperatively.
Guideline-Based Recommendations
Diagnosis
Diagnosis of PMOS according to the Rotterdam criteria.
Management
Metabolic-bariatric surgery (MBS) as an effective treatment for obesity in PMOS.
Monitoring & Follow-up
Follow-up assessments at 1, 3, 6, and 12 months post-surgery.
Risks
Increased risk of type 2 diabetes, cardiovascular disease, and endometrial cancer in women with PMOS.
Patient & Prescribing Data
Women with PMOS and obesity undergoing MBS.
MBS leads to significant metabolic improvements and weight loss.
Clinical Best Practices
Utilize group-based trajectory modeling to identify weight-loss patterns post-MBS.
Conduct thorough preoperative assessments to exclude patients with contraindications.
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
